Challenge To US Homeopathic Drugs Regulation Rings Post-Chevron And OTC Monograph Bells

The US Food and Drug Administration’s regulatory policy for homeopathic drugs is targeted in a challenge to the agency’s authority leveraging the Supreme Court’s decision striking the Chevron doctrine of deference.

“That decision is central to this case,” says Jonathan Emord, the attorney representing the Alliance for Natural Health USA advocacy group and homeopathic firm Meditrend Inc. in a complaint filed...